After successfully completing two trials, SWIFT-1 and SWIFT-2, for its long-acti...
Onward Medical revealed that it has received a major grant from the Christopher ...
In a decision expected to limit Brussels’ merger authority, American gene sequen...
Sanofi has announced that tolebrutinib, a BTK inhibitor, failed in two out of th...
Athira Pharma’s Phase 2/3 Alzheimer’s disease trial has ended in failure. The tr...
Shanghai Allist Pharmaceuticals has significantly bolstered its position in Chin...
Emergent BioSolutions’ smallpox vaccine has received expanded approval from the ...
As part of its strategy to expand PET imaging capabilities, Siemens Healthineers...
Bavarian Nordic announced today that its vaccine, JYNNEOS, has been licensed by ...
McKesson has planned to enhance its oncology platform with a significant investm...
It appears that restructuring is the trend for many big pharmaceutical companies...
Germany has provided 100,000 doses of the Mpox vaccine from its armed forces to ...
Kidney disease biotech Pathalys Pharma has raised $105 million in a Series B fun...
Eli Lilly’s weight loss drug, tirzepatide, has shown a 94% reduction in the inci...
Ascendis Pharma should be in a good position to launch its hormone replacement t...
Pfizer reported top-line interim safety and immunogenicity outcomes from Substud...
